MESOBLAST LTD (MEOBF) — Earnings Call Analysis & IR Page

MESOBLAST LTD is a Healthcare company operating in Biotechnology with a $2.47B market cap.

Most recent earnings call: Q2 FY26 on Feb 27, 2026.

10 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

IR URL not yet extracted for MEOBF.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 10 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MEOBF.

$ curl https://api.spokenalpha.com/v1/companies/MEOBF

Get an API key API docs

FAQ

Frequently asked about MEOBF

Where can I find MESOBLAST LTD's (MEOBF) earnings call transcripts?

Spoken Alpha indexes MEOBF's earnings call transcripts at https://spokenalpha.com/companies/MEOBF. Each call links to attributed speakers and parsed analyst Q&A.

When was MESOBLAST LTD's most recent earnings call?

MESOBLAST LTD (MEOBF) held its most recent earnings call on 2026-02-27, covering fiscal Q2 2026.

What sector is MEOBF in?

MESOBLAST LTD (MEOBF) operates in the Healthcare sector (Biotechnology industry).

Overview